Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Horban A

Collect these papers and discover other ones on Labmeeting. Learn more.

Transmission of drug-resistant HIV-1 is stabilizing in Europe.

+ cite this

+ View Abstract

Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, Hamouda O, Kücherer C, Struck D, Schmit JC, Asjö B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A,

(show remaining authors)

The Journal of infectious diseases 200(10):1503-8, 2009 Nov 15 - Who cited this? | PubMed ID: 19835478 | Fulltext

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

+ cite this

+ View Abstract

Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD, and EuroSIDA Study Group

The Journal of infectious diseases 200(5):687-97, 2009 Sep 1 - Who cited this? | PubMed ID: 19604043 | Fulltext

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

+ cite this

+ View Abstract

Flisiak R, Feinman SV, Jablkowski M, Horban A, Kryczka W, Pawlowska M, Heathcote JE, Mazzella G, Vandelli C, Nicolas-Métral V, Grosgurin P, Liz JS, Scalfaro P, Porchet H, and Crabbé R

Hepatology (Baltimore, Md.) 49(5):1460-8, 2009 May - Who cited this? | PubMed ID: 19353740 | Fulltext

Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone.

+ cite this

+ View Abstract

Flandre P, Delaugerre C, Ghosn J, Chaix ML, Horban A, Girard PM, Gladysz A, Cohen-Codar I, Van PN, Taburet AM, Rouzioux C, Delfraissy JF, and MONARK Study Group

Antiviral therapy 14(1):93-7, 2009 - Who cited this? | PubMed ID: 19320241 | Fulltext

[Recommendations of an expert group appointed by the Polish Gynaecological Society on Prevention of Mother-to-Child Transmission of HIV].

+ cite this

+ View Abstract

Niemiec T, Kotarski J, Radowicki S, Horban A, Marczyńska M, and Debski R

Ginekologia polska 80(1):59-62, 2009 Jan - Who cited this? | PubMed ID: 19323062 | Fulltext

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

+ cite this

+ View Abstract

Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A,

(show remaining authors)

Retrovirology 6:49, 2009 - Who cited this? | PubMed ID: 19457244 | Fulltext

Maraviroc for previously treated patients with R5 HIV-1 infection.

+ cite this

+ View Abstract

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW,

(show remaining authors)

The New England journal of medicine 359(14):1429-41, 2008 Oct 2 - Who cited this? | PubMed ID: 18832244 | Fulltext

The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.

+ cite this

+ View Abstract

Flisiak R, Horban A, Gallay P, Bobardt M, Selvarajah S, Wiercinska-Drapalo A, Siwak E, Cielniak I, Higersberger J, Kierkus J, Aeschlimann C, Grosgurin P, Nicolas-Métral V, Dumont JM, Porchet H, Crabbé R,

(show remaining authors)

Hepatology (Baltimore, Md.) 47(3):817-26, 2008 Mar - Who cited this? | PubMed ID: 18302285 | Fulltext

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.

+ cite this

+ View Abstract

Delfraissy JF, Flandre P, Delaugerre C, Ghosn J, Horban A, Girard PM, Norton M, Rouzioux C, Taburet AM, Cohen-Codar I, Van PN, and Chauvin JP

AIDS (London, England) 22(3):385-93, 2008 Jan 30 - Who cited this? | PubMed ID: 18195565 | Fulltext

Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999.

+ cite this

+ View Abstract

Mocroft A, Horban A, Clotet B, d'Arminio Monforte A, Bogner JR, Aldins P, Staub T, Antunes F, Katlama C, Lundgren JD, and

HIV medicine 9(1):41, 2008 Jan - Who cited this? | PubMed ID: 18199171 | Fulltext

Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.

+ cite this

+ View Abstract

Pawiński T, Pulik P, Gralak B, and Horban A

Acta poloniae pharmaceutica 65(1):93-100, 2008 - Who cited this? | PubMed ID: 18536180 | Fulltext

Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.

+ cite this

+ View Abstract

Gatell J, Salmon-Ceron D, Lazzarin A, Van Wijngaerden E, Antunes F, Leen C, Horban A, Wirtz V, Odeshoo L, Van den Dungen M, Gruber C, Ledesma E, and SWAN Study Group

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 44(11):1484-92, 2007 Jun 1 - Who cited this? | PubMed ID: 17479947 | Fulltext

[Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland].

+ cite this

+ View Abstract

Stańczak GP, Stańczak JJ, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynkad M, Jabłonowska E, Małolepsza E, and Horban A

Przeglad epidemiologiczny 61(1):29-34, 2007 - Who cited this? | PubMed ID: 17702436 | Fulltext

[Factors influencing time from exposure to post-exposure prophylaxis of HIV infection in patients consulted in 2001-2004 in out-patient clinic of Hospital for Infectious Diseases in Warsaw].

+ cite this

+ View Abstract

Kowalska JD, Firlag-Burkacka E, Niezabitowska M, and Horban A

Przeglad epidemiologiczny 61(2):357-62, 2007 - Who cited this? | PubMed ID: 17956054 | Fulltext

Central nervous system as a possible site of HCV replication.

+ cite this

+ View Abstract

Bednarska A, Horban A, and Radkowski M

Przeglad epidemiologiczny 61(4):739-45, 2007 - Who cited this? | PubMed ID: 18572506 | Fulltext

Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.

+ cite this

+ View Abstract

Podlasin RB, Wiercinska-Drapalo A, Olczak A, Beniowski M, Smiatacz T, Malolepsza E, Juszczyk J, Leszczyszyn-Pynka M, Mach T, Mian M, Knysz B, and Horban A

Infection 34(4):196-200, 2006 Aug - Who cited this? | PubMed ID: 16896577 | Fulltext

Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.

+ cite this

+ View Abstract

Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W,

(show remaining authors)

HIV medicine 7(3):146, 2006 Apr - Who cited this? | PubMed ID: 16494628 | Fulltext

The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes.

+ cite this

+ View Abstract

van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A,

(show remaining authors)

Journal of acquired immune deficiency syndromes (1999) 41(3):352-60, 2006 Mar - Who cited this? | PubMed ID: 16540937 | Fulltext

[Results of 48 weeks lamivudine treatment of patients with chronic hepatitis B and HBeAg (-)].

+ cite this

+ View Abstract

Berak H, Wasilewski M, Horban A, Stańczak JJ, and Cybula A

Przeglad epidemiologiczny 60(2):247-51, 2006 - Who cited this? | PubMed ID: 16964675 | Fulltext

[Results of 48 weeks lamivudine treatment of patients with chronic hepatitis B and HBeAg (+)].

+ cite this

+ View Abstract

Berak H, Wasilewski M, Horban A, Stańczak JJ, and Cybula A

Przeglad epidemiologiczny 60(2):253-7, 2006 - Who cited this? | PubMed ID: 16964676 | Fulltext

[Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C].

+ cite this

+ View Abstract

Horban A, Wasilewski M, Berak H, Stańczak JJ, Bardadin K, and Paprocka H

Przeglad epidemiologiczny 60(3):563-9, 2006 - Who cited this? | PubMed ID: 17249181 | Fulltext

[Comparison of early virologic response among patients with chronic hepatitis C infected with genotype non 2/3 treated with pegylated interferon alfa-2B and ribavirin in dependence with hepatic fibrosis stages].

+ cite this

+ View Abstract

Berak H, Kołakowska-Rzadzka A, Wasilewski M, Stańczak JJ, Krzysztof B, Walewska-Zielecka B, and Horban A

Przeglad epidemiologiczny 60(4):673-6, 2006 - Who cited this? | PubMed ID: 17682747 | Fulltext

[Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].

+ cite this

+ View Abstract

Kowalska JD, Firlag-Burkacka E, Niezabitowska M, Bakowska E, Ignatowska A, Pulik P, and Horban A

Przeglad epidemiologiczny 60(4):789-94, 2006 - Who cited this? | PubMed ID: 17682761 | Fulltext

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

+ cite this

+ View Abstract

Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A,

(show remaining authors)

The Journal of infectious diseases 192(6):958-66, 2005 Sep 15 - Who cited this? | PubMed ID: 16107947 | Fulltext

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

+ cite this

+ View Abstract

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, and EuroSIDA Study Group

The Journal of infectious diseases 192(6):992-1002, 2005 Sep 15 - Who cited this? | PubMed ID: 16107951 | Fulltext

Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels.

+ cite this

+ View Abstract

Radkowski M, Horban A, Gallegos-Orozco JF, Pawelczyk A, Jablonska J, Wilkinson J, Adair D, and Laskus T

The Journal of infectious diseases 191(10):1730-3, 2005 May 15 - Who cited this? | PubMed ID: 15838801 | Fulltext

Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.

+ cite this

+ View Abstract

Johnson M, Nieto-Cisneros L, Horban A, Arasteh K, Gonzalez-Garcia J, Artigas JG, Clotet B, Danise A, Landman R, Proll S, Snowden W, Foreman R, and Smith P

HIV medicine 6(2):107, 2005 Mar - Who cited this? | PubMed ID: 15807716 | Fulltext

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.

+ cite this

+ View Abstract

Olsen CH, Gatell J, Ledergerber B, Katlama C, Friis-Møller N, Weber J, Horban A, Staszewski S, Lundgren JD, Phillips AN, and EuroSIDA Study Group

AIDS (London, England) 19(3):319-30, 2005 Feb 18 - Who cited this? | PubMed ID: 15718843 | Fulltext

[Epidemic outbreak of acute hepatitis C--clinical course, histology and effectiveness of therapy].

+ cite this

+ View Abstract

Cianciara J, Jabłońska J, Horban A, and Walewska-Zielecka B

Przeglad epidemiologiczny 59(2):385-94, 2005 - Who cited this? | PubMed ID: 16190545 | Fulltext

[Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)].

+ cite this

+ View Abstract

Juszczyk J, Baka-Cwierz B, Beniowski M, Berak H, Bolewska B, Boroń-Kaczmarska A, Cianciara J, Cieśla A, Dziambor A, Gasiorowski J, Gietka A, Gliwińska E, Gładysz A, Gonciarz Z, Halota W, Horban A,

(show remaining authors)

Przeglad epidemiologiczny 59(3):651-60, 2005 - Who cited this? | PubMed ID: 16433307 | Fulltext

[Utility of multiplex PCR for diagnosis of neurological disorders in HIV-infected patients and patients with AIDS].

+ cite this

+ View Abstract

Bednarska A, Podlasin R, Karczewski G, Loch T, Horban A, and Radkowski M

Przeglad epidemiologiczny 59(4):873-9, 2005 - Who cited this? | PubMed ID: 16729429 | Fulltext

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.

+ cite this

+ View Abstract

Mocroft A, Ledergerber B, Viard JP, Staszewski S, Murphy M, Chiesi A, Horban A, Hansen AB, Phillips AN, Lundgren JD, and EuroSIDA Study Group

The Journal of infectious diseases 190(11):1947-56, 2004 Dec 1 - Who cited this? | PubMed ID: 15529259 | Fulltext

Updated European recommendations for the clinical use of HIV drug resistance testing.

+ cite this

+ View Abstract

Vandamme AM, Sönnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, Banhegyi D, Boucher C, Brun-Vézinet F, Camacho R, Clevenbergh P, Clumeck N, Dedes N, De Luca A, Doerr HW, Faudon JL,

(show remaining authors)

Antiviral therapy 9(6):829-48, 2004 Dec - Who cited this? | PubMed ID: 15651743 | Fulltext

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

+ cite this

+ View Abstract

van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, Wood R, Bloch M, Katlama C, Kastelein JJ, Schechter M, Murphy RL, Horban A, Hall DB, Lange JM, and Reiss P

PLoS medicine 1(1), 2004 Oct - Who cited this? | PubMed ID: 15526045 | Fulltext

Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.

+ cite this

+ View Abstract

Phillips AN, Ledergerber B, Horban A, Reiss P, Chiesi A, Kirk O, Mulchany F, Fisher M, Machala L, Lundgren JD, and EuroSIDA Study Group

AIDS (London, England) 18(13):1795-804, 2004 Sep 3 - Who cited this? | PubMed ID: 15316340 | Fulltext

Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.

+ cite this

+ View Abstract

Dragsted UB, Mocroft A, Vella S, Viard JP, Hansen AB, Panos G, Mercey D, Machala L, Horban A, Lundgren JD, and EuroSIDA study group

The Journal of infectious diseases 190(1):148-55, 2004 Jul 1 - Who cited this? | PubMed ID: 15195254 | Fulltext

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

+ cite this

+ View Abstract

van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G,

(show remaining authors)

Lancet 363(9417):1253-63, 2004 Apr 17 - Who cited this? | PubMed ID: 15094269 | Fulltext

Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects.

+ cite this

+ View Abstract

Blanckenberg DH, Wood R, Horban A, Beniowski M, Boron-Kaczmarska A, Trocha H, Halota W, Schmidt RE, Fatkenheuer G, Jessen H, Lange JM, and CHARM Study Group

AIDS (London, England) 18(4):631-40, 2004 Mar 5 - Who cited this? | PubMed ID: 15090768 | Fulltext

Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8.

+ cite this

+ View Abstract

Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, Nowicki M, Rakela J, and Laskus T

The Journal of general virology 85(Pt 1):47-59, 2004 Jan - Who cited this? | PubMed ID: 14718619 | Fulltext

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

+ cite this

+ View Abstract

van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F,

(show remaining authors)

AIDS (London, England) 17(7):987-99, 2003 May 2 - Who cited this? | PubMed ID: 12700448 | Fulltext

High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy-naive individuals from the Warsaw cohort.

+ cite this

+ View Abstract

Horban A, Stanczak JJ, Bakowska E, Tobolewska EJ, Przybylska-Stengiel KJ, Stanczak GP, and Burkacka E

Infection 30(6):356-9, 2002 Dec - Who cited this? | PubMed ID: 12478325 | Fulltext

Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.

+ cite this

+ View Abstract

Schacker TW, Nguyen PL, Martinez E, Reilly C, Gatell JM, Horban A, Bakowska E, Berzins B, van Leeuwen R, Wolinsky S, Haase AT, and Murphy RL

The Journal of infectious diseases 186(8):1092-7, 2002 Oct 15 - Who cited this? | PubMed ID: 12355359 | Fulltext

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.

+ cite this

+ View Abstract

van der Valk M, Kastelein JJ, Murphy RL, van Leth F, Katlama C, Horban A, Glesby M, Behrens G, Clotet B, Stellato RK, Molhuizen HO, Reiss P, and Atlantic Study Team

AIDS (London, England) 15(18):2407-14, 2001 Dec 7 - Who cited this? | PubMed ID: 11740191 | Fulltext

Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.

+ cite this

+ View Abstract

Wit FW, Wood R, Horban A, Beniowski M, Schmidt RE, Gray G, Lazzarin A, Lafeuillade A, Paes D, Carlier H, van Weert L, de Vries C, van Leeuwen R, and Lange JM

AIDS (London, England) 15(18):2423-9, 2001 Dec 7 - Who cited this? | PubMed ID: 11740193 | Fulltext

[Tuberculosis and mycobacteriosis important opportunistic disease in AIDS patients].

+ cite this

+ View Abstract

Zalewska-Schönthaler N, Schönthaler-Humiecka J, Podlasin R, Cholewińska G, Rzeszkowicz T, Mikuła T, and Horban A

Przeglad epidemiologiczny 55 Suppl 3:117-25, 2001 - Who cited this? | PubMed ID: 11984937 | Fulltext

[Nested PCR in the diagnosis of Pneumocystis carinii pneumonia (PCP) in AIDS patients].

+ cite this

+ View Abstract

Gołab E, Sobolewska A, Bitkowska E, Bednarska A, Berak H, Dzbeński TH, and Horban A

Wiadomosci parazytologiczne 47(3):521-5, 2001 - Who cited this? | PubMed ID: 16894769 | Fulltext

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes.

+ cite this

+ View Abstract

Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, and Rakela J

The Journal of infectious diseases 181(2):442-8, 2000 Feb - Who cited this? | PubMed ID: 10669324 | Fulltext

Distribution of hepatitis C virus genotypes in Poland.

+ cite this

Stańczak JJ, Opoka-Kegler J, Czerwionka-Szaflarska M, Karczewska K, Woźniakowska-Gesicka T, and Horban A

Journal of hepatology 31(3):574, 1999 Sep - Who cited this? | PubMed ID: 10488722 | Fulltext

[Antiretroviral therapy in pregnant women with HIV].

+ cite this

+ View Abstract

Niemiec KT, Horban A, Chazan B, and Firlag-Burkacka E

Ginekologia polska 69(11):820-6, 1998 Nov - Who cited this? | PubMed ID: 10337075 | Fulltext

[Humoral response to HBV antigens in acute and chronic hepatitis B].

+ cite this

+ View Abstract

Swiderska H, Nitkiewicz J, Piwowarska A, Jończyk M, Cholewińska G, Tomaszewska D, and Horban A

Przeglad epidemiologiczny 52(4):469-81, 1998 - Who cited this? | PubMed ID: 10321091 | Fulltext

Search Google Scholar for Horban A

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!